Evidence map›Paper›PMID 37501607›Full record

ArticleClinical cardiology2023

Noncontrast cardiac computed tomography-derived mitral annular calcification scores in mitral valve disease.

Jie Hou, Yu Sun, Huishan Wang, Libo Zhang, Jinglong Shi, Hongrui You, Rongrong Zhang, Benqiang Yang

Open access · goldAbstract read
In one paragraph

Article in Clinical cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jie HouCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, China.ORCID http://orcid.org/0000-0003-2349-9230
Yu SunCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, China.
Huishan WangDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.ORCID http://orcid.org/0000-0001-6523-7488
Libo ZhangDepartment of Radiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Jinglong ShiDepartment of Radiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Hongrui YouDepartment of Radiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Rongrong ZhangDepartment of Radiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Benqiang YangDepartment of Radiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.ORCID http://orcid.org/0000-0001-8609-3655
Liaoning University · CNGeneral Hospital of Shenyang Military Region · CN

Funding

Key research and development project of Liaoning Province of China 2020JH2/10300119National Natural Science Foundation of China 82070239Project of science and technology of Liaoning Province of China 2018225024
6 · The paper itself

Abstract

BACKGROUND AND

aimsMitral annular calcification (MAC) by computed tomography (CT) is reported as an independent predictor of poor outcomes. However, it currently remains unclear if quantitative MAC parameters provide more value for mitral valve disease (MVD) management, therefore, we examined the prognostic value of MAC scores using noncontrast cardiac-CT in MVD patients.

methodsBetween January 2020 and December 2021, we prospectively enrolled 300 consecutive patients with MVD (MAC-present = 80 and MAC-absent = 220) undergoing preoperative cardiac-CT and mitral valve (MV) surgery. Noncontrast cardiac-CT images were used to qualitatively detect MAC (present or absent) and evaluate MAC scores. For analyses, we also collected baseline clinical data, intraoperative conversion (from MV repair to MV replacement), and follow-up arrhythmia data.

resultsCompared with the MAC-absent group, MAC-present patients were older (62 ± 7 vs. 58 ± 9 years, p < .001), mostly women (55% vs. 39.5%, p = .017), and also had aortic valve calcification (57.5% vs. 23.2%, p < .001), mitral stenosis (82.5% vs. 61.8%, p < .001), atrial fibrillation (30% vs. 11.8%, p < .001), and larger left atrial end-diastolic dimension (LADD, 49 [44-56] versus 46 [41-50], p = .001]. Furthermore, MAC-present patients underwent more MV replacements (61.8% vs. 82.5%, p = .001) and experienced a higher intraoperative conversion prevalence (11.8% vs. 61.3%, p < .001). Multiple logistic regression analyses showed that the female gender (odds ratio [OR]/95% confidence interval [CI]/p = 2.001/1.042-3.841/0.037) and MAC scores (OR/95% CI/p = 10.153/4.434-23.253/p < .001) were independent predictors of intraoperative conversion. During a follow-up of 263 ± 134 days, MAC-present patients had more arrhythmias (42.5% vs. 9.5%, p < .001). Also, MAC-scores (hazard ratio [HR]/95% CI/p = 6.841/3.322-14.089/p < .001) and LADD (HR/95% CI/p = 1.039/1.018-1.060/p < .001) were independently associated with arrhythmias by Cox regression analyses.

conclusionsNoncontrast cardiac CT-derived MAC-scores showed a high risk for intraoperative conversion and follow-up arrhythmias in MVD-patients.

Indexed as

Aortic Valve StenosisHeart Valve DiseasesAortic ValveFemaleHumansMaleMitral ValveTomography, X-Ray Computedarrhythmiamitral annular calcificationmitral annular calcification scoremitral valve diseasenoncontrast cardiac computed tomography

Identifiers

PMID37501607
PMCPMC10642324
OpenAlexW4385331398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.